MDxHealth Launches CE-Marked SelectMDx IVD PCR Kit and UrNCollect Device
MDxHealth Launches CE-Marked SelectMDx IVD PCR Kit and UrNCollect Device NEWS RELEASE / REGULATED INFORMATION / INSIDE INFORMATION / FOR EX-US ONLY […]
Annual General Shareholders’ Meeting
IRVINE, CA, and HERSTAL, BELGIUM – 15:45 CEST, May 26 2017 – MDxHealth SA (Euronext: MDXH.BR) held today its Annual General Shareholders’ Meeting in Diegem. The shareholders approved all agenda items of the Annual General Shareholders’ Meeting, including the financial statements for the financial year ended December 31, 2016. In addition, the company held an Extraordinary […]
SelectMDx for Prostate Cancer Guides Patient Selection for mpMRI
SelectMDx for Prostate Cancer Guides Patient Selection for mpMRI NEWS RELEASE / REGULATED INFORMATION / INSIDE INFORMATION ABSTRACT #MP33-17 […]
ConfirmMDx Improves Prostate Cancer Diagnosis in African American Men
ConfirmMDx Improves Prostate Cancer Diagnosis in African American Men NEWS RELEASE ABSTRACT #PD07-04 IRVINE, CA, and HERSTAL, BELGIUM – 16:00 CEST, May 12, 2017 – MDxHealth SA (Euronext: MDXH.BR) today announced that results from a retrospective study demonstrated that its ConfirmMDx® for Prostate Cancer test improved the identification of African American men at […]
MDxHealth Trading Update: January to April 2017
MDxHealth Trading Update: January to April 2017 NEWS RELEASE / REGULATED INFORMATION / INSIDE INFORMATION […]
MDxHealth Epigenetic Biomarkers Identify Men at Increased Risk of Prostate Cancer Recurrence
MDxHealth Epigenetic Biomarkers Identify Men at Increased Risk of Prostate Cancer Recurrence NEWS RELEASE / REGULATED INFORMATION / INSIDE INFORMATIONABSTRACT #490, POSTER SESSION 36 Data presented at EAU […]
MDxHealth Awarded a Federal Supply Schedule Contract for ConfirmMDx for Prostate Cancer
MDxHealth Awarded a Federal Supply Schedule Contract for ConfirmMDx for Prostate Cancer NEWS RELEASE / REGULATED INFORMATION / INSIDE INFORMATION IRVINE, CA, and HERSTAL, BELGIUM – February 01, 2017 – MDxHealth SA (Euronext: MDXH.BR) today announced that it has been awarded a US Government Federal Supply Schedule Contract for medical laboratory testing services for ConfirmMDx® for Prostate Cancer. […]
MDxHealth Reports Financial Year 2019 Results and Provides Outlook for 2020
Conference call with Q&A today at 09:00 CET / 08:00 GMT, details provided below IRVINE, CA, and HERSTAL, BELGIUM – February
MDxHealth Notice of 2019 Full Year Results
IRVINE, CA, and HERSTAL, BELGIUM – January 10, 2020 – MDxHealth SA (Euronext: MDXH.BR), a commercial-stage innovative molecular diagnostics company, today announced that it will release its financial results for the full year ended 31 December 2019 on Wednesday 26 February 2020. Michael K. McGarrity, Chief Executive Officer and Ron Kalfus, Chief Financial Officer, will host a conference […]
MDxHealth (R): MDxHealth Announces Favorable Draft Medicare Coverage for the SelectMDx Test
IRVINE, CA – August 26, 2019 – MDxHealth SA (Euronext: MDXH.BR), a commercial-stage innovative molecular diagnostics company,
